Welcome to the Hu Lab
The lab is using molecular, cellular, biochemical, genetic, structural, 'omics', bioinformatics and imaging approaches to studying how cancer cell behaviors are regulated at the transcription and epigenetic levels. The ultimate goal is to develop novel anti-cancer agents for cancer treatment. We have developed several research programs that are integrated with technology development, basic biological research, and clinical translation. The current technology developments involve bimolecular fluorescence complementation (BiFC) and BiFC-derived technologies. The biological research is centered on the transcriptional and epigenetic regulation of cancer cell growth and therapeutic response. The clinical translational research is aimed at understanding the molecular mechanisms of therapy-resistant prostate cancer and development of novel therapeutics. In addition, we are developing novel treatment approaches for lung cancer and pancreatic cancer.
The Hu lab fosters an environment that focuses on scientific excellence and career growth of all lab members. The weekly lab meeting, lab journal club, written progress report, and one-on-one meeting are key opportunities for students to develop their independent research ability and improve their scientific presentation skills. Each graduate student has won at least one graduate research fellowship, and many of postdoctoral research associates and visiting scholars have received national and internal fellowships. The Hu lab members have also won numerous travel awards and best poster / best presenter awards internal and external to Purdue.